Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer

Oncogene

Volumn 22, Issue 36, 2003, Pages 5694-5701

  Yang, Gong ^a   Thompson, Jennifer Anne ^a   Fang, Bingliang ^a   Liu, Jinsong ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

H ras; Ovarian cancer; Retrovirus; SiRNA

Indexed keywords

GREEN FLUORESCENT PROTEIN; RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; NUDE MOUSE; ONCOGENE H RAS; OVARY CANCER; PRIORITY JOURNAL; RETROVIRUS; SIGNAL TRANSDUCTION; TUMOR GROWTH; WILD TYPE;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE SILENCING; GENES, RAS; HUMANS; MICE; MICE, INBRED BALB C; OVARIAN NEOPLASMS; RETROVIRIDAE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0041335551     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206858     Document Type: Article

References (34)

1. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M. (1988). Cell, 53, 549-554.
2. Barbacid M. (1987). Annu. Rev. Biochem., 56, 779-827.
3. Barton GM and Medzhitov R. (2002). Proc. Natl. Acad. Sci. USA, 99, 14943-14945.
4. Bos JL. (1989). Cancer Res., 49, 4682-4689.
5. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ and Vogelstein B. (1987a). Nature, 327, 293-297.
6. Bos JL, Verlaan-de Vries M, van der Eb, AJ, Janssen JW, Delwel R, Lowenberg B and Colly LP. (1987b). Blood, 69, 1237-1241.
7. Brummelkamp TR, Bernards R and Agami R. (2002). Cancer Cell, 2, 243-247.
8. Cuatrecasas M, Erill N, Musulen E, Costa I, Matias-Guiu X and Prat J. (1998). Cancer, 82, 1088-1095.
9. Cuatrecasas M, Villanueva A, Matias-Guiu X and Prat J. (1997). Cancer, 79, 1581-1586.
10. Devroe E and Silver PA. (2002). BMC Biotechnol., 2, 15.
11. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
12. Enomoto T, Weghorst CM, Inoue M, Tanizawa O and Rice JM. (1991). Am. J. Pathol., 139, 777-785.
13. Forrester K, Almoguera C, Han K, Grizzle WE and Perucho M. (1987). Nature, 327, 298-303.
14. Hammond SM, Bernstein E, Beach D and Hannon GJ. (2000). Nature, 404, 293-296.
15. Ichikawa Y, Nishida M, Suzuki H., Yoshida S, Tsunoda H, Kubo T, Uchida K and Miwa M. (1994). Cancer Res., 54, 33-35.
16. Jacque JM, Triques K and Stevenson M. (2002). Nature, 26, 26.
17. Liu J, Prolla G, Rostagno A, Chiarle R, Feiner H and Inghirami G. (2000). Oncogene, 19, 2767-2773.
18. Liu J, Yang G, Thompson JA and Patterson A. (2003). Submitted.
19. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ and Kay MA. (2002). Nature, 418, 38-39.
20. Miyagishi M and Taira K. (2002). Nat. Biotechnol., 20, 497-500.
21. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS and Tsao SW. (1993). Cancer Res., 53, 1489-1492.
22. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ and Conklin DS. (2002a). Genes Dev., 16, 948-958.
23. Paddison PJ, Caudy AA and Hannon GJ. (2002b). Proc. Natl. Acad. Sci. USA, 99, 1443-1448.
24. Paddison PJ and Hannfon GJ. (2002). Cancer Cell, 2, 17-23.
25. Patton SE, Martin ML, Nelsen LL, Fang X, Mills GB, Bast Jr RC and Ostrowski MC. (1998). Cancer Res., 58, 2253-2259.
26. Paul CP, Good PD, Winer I and Engelke DR. (2002). Nat. Biotechnol., 20, 505-508.
27. Shields JM, Pruitt K, McFall A, Shaub A and Der CJ. (2000). Trends Cell Biol., 10, 147-154.
28. Singer G, Oldt III R, Cohen Y, Wang BG, Sidransky D, Kurman RJ and Shih Ie M. (2003). J. Natl. Cancer Inst., 95, 484-486.
29. Sui G, Soohoo C, Affar el B, Gay F, Shi Y and Forrester WC. (2002). Proc. Natl. Acad Sci. USA, 99, 5515-5120.
30. Tabin CJ, Bradley SM, Bargmann CI, Weinbert RA et al. (1982). Nature, 300, 143-149.
31. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC and Birrer MJ. (1993). Cancer Res., 53, 3103-3108.
32. Varras MN, Sourvinos G, Diakomanolis E, Koumantakis E, Flouris GA, Lekka-Katsouli J, Michalas S and Spandidos DA. (1999). Oncology, 56, 89-96.
33. Visvanathan KV, Pocock RD and Summerhayes IC. (1988). Oncogene Res., 3, 77-86.
34. Yu JY, DeRuiter SL and Turner DL. (2002). Proc. Natl. Acad. Sci. USA, 99, 6047-6052.